Supplementary Table 3 showed that PLC patients who had a thyroid cancer history had a decreased PLC-specific death [hazard ratio (HR) = 0.618; 95% confidence interval (CI): 0.477–0.801, P < 0.001]. This evidence concerns the gene HSPG2 and thyroid gland carcinoma.